We are live on ! Find out more
PCA

Personal Capital Advisors Portfolio holdings

AUM $20.6B
1-Year Est. Return 13.65%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
-13.65%
3 Year Est. Return
+17.55%
5 Year Est. Return
+33.04%
10 Year Est. Return
AUM
$21.4B
AUM Growth
-$315M
Cap. Flow
+$708M
Cap. Flow %
3.31%
Top 10 Hldgs %
40.75%
Holding
565
New
16
Increased
181
Reduced
269
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Consumer Staples 4.54%
3 Utilities 4.15%
4 Materials 3.97%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
476
Phillips 66
PSX
$81.2B
$206K ﹤0.01%
+2,388
New +$201K
HUM icon
477
Humana
HUM
$43.7B
$204K ﹤0.01%
469
-7
-1% -$2.93K
REET icon
478
iShares Global REIT ETF
REET
$5.13B
$204K ﹤0.01%
6,973
-1,288
-16% -$36.8K
PEGA icon
479
Pegasystems
PEGA
$5.23B
$201K ﹤0.01%
4,984
SIRI icon
480
SiriusXM
SIRI
$10.3B
$183K ﹤0.01%
2,765
-129
-4% -$8.12K
ROI
481
DELISTED
RiskOn International, Inc. Common Stock
ROI
$125K ﹤0.01%
1,803
-49
-3% -$3.64K
SPOK icon
482
Spok Holdings
SPOK
$235M
$110K ﹤0.01%
13,825
+3,382
+32% +$30.7K
USA icon
483
Liberty All-Star Equity Fund
USA
$1.84B
$88K ﹤0.01%
10,862
-59
-0.5% -$454
RIG icon
484
Transocean
RIG
$5.69B
$79K ﹤0.01%
17,347
VERU icon
485
Veru
VERU
$37.4M
$53K ﹤0.01%
1,095
-1
-0.1% -$54
GNW icon
486
Genworth Financial
GNW
$3.71B
$52K ﹤0.01%
13,825
MNKD icon
487
MannKind Corp
MNKD
$1.31B
$39K ﹤0.01%
10,530
GNCA
488
DELISTED
Genocea Biosciences, Inc.
GNCA
$19K ﹤0.01%
15,000
ATHX
489
DELISTED
Athersys, Inc. Common Stock
ATHX
$12K ﹤0.01%
800
MRKR icon
490
Marker Therapeutics
MRKR
$19M
$11K ﹤0.01%
2,571
TXMD icon
491
TherapeuticsMD
TXMD
$24M
$5K ﹤0.01%
260
-1
-0.4% -$16
ADI icon
492
Analog Devices
ADI
$184B
-1,216
Closed -$214K
AVEM icon
493
Avantis Emerging Markets Equity ETF
AVEM
$26.2B
-3,793
Closed -$240K
BALL icon
494
Ball Corp
BALL
$16.8B
-96,126
Closed -$9.29M
BDX icon
495
Becton Dickinson
BDX
$47B
-1,970
Closed -$483K
BILL icon
496
BILL Holdings
BILL
$4.81B
-38,547
Closed -$9.6M
BNY
497
Bank of New York Mellon
BNY
$108B
-6,265
Closed -$364K
BR icon
498
Broadridge
BR
$18.6B
-1,320
Closed -$241K
CCI icon
499
Crown Castle
CCI
$32.3B
-1,113
Closed -$217K
CEF icon
500
Sprott Physical Gold and Silver Trust
CEF
$7.86B
-22,695
Closed -$403K

Similar funds

Personal Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Personal Capital Advisors held 565 positions worth $21.4B, down 1.5% from $21.7B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Personal Capital Advisors deployed $708M of net new capital in Q1 2022, opening 16 new positions and adding to 181 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 38,535 shares worth $8.74M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Consumer Staples and Utilities.

On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $373M trimmed.

  • Personal Capital Advisors's largest Q1 2022 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 38,535 shares worth $8.74M.
  • Personal Capital Advisors added most to Schwab US TIPS ETF in Q1 2022, an estimated $394M increase.
  • Personal Capital Advisors's biggest Q1 2022 reduction was iShares TIPS Bond ETF, cutting an estimated $373M.
  • Personal Capital Advisors fully exited Edwards Lifesciences in Q1 2022, selling an estimated $67.8M.
  • Personal Capital Advisors's ten largest holdings make up 41% of its $21.4B portfolio in Q1 2022.
  • Personal Capital Advisors opened 16 new positions and closed 72 in Q1 2022.
  • Personal Capital Advisors's portfolio value fell 1.5% quarter-over-quarter to $21.4B.

Based on Personal Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.